Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wayne Tam

Showing results (71-80 of 140) with videos related to

Pageof 14
Sort By:
American Journal of Clinical Pathology|September 25, 2025
Guide to the diagnosis of lymphoid neoplasms in blood and bone marrow: A Bone Marrow Pathology Group approachKathryn Foucar, Adam Bagg, Daniel A Arber, et al.
Clinical Lymphoma, Myeloma & Leukemia|August 1, 2024
Expression of CD6 in Aggressive NK/T-cell Neoplasms and Assessment as a Potential Therapeutic Target: A Bone Marrow Pathology Group StudyXiaoxian Zhao, Chad M McCall, Jared G Block, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 22, 2012
Pegylated liposomal doxorubicin, rituximab, cyclophosphamide, vincristine, and prednisone in AIDS-related lymphoma: AIDS Malignancy Consortium Study 047Alexandra M Levine, Ariela Noy, Jeannette Y Lee, et al.
Blood|October 8, 2021
Oncogenic role of the SOX9-DHCR24-cholesterol biosynthesis axis in IGH-BCL2+ diffuse large B-cell lymphomasYajie Shen, Jingqi Zhou, Kui Nie, et al.
Leukemia & Lymphoma|May 4, 2019
Digital droplet PCR and next-generation sequencing refine minimal residual disease monitoring in acute lymphoblastic leukemiaIrene Della Starza, Lucia Anna De Novi, Alessandra Santoro, et al.
Blood|September 6, 2018
Five-year follow-up of lenalidomide plus rituximab as initial treatment of mantle cell lymphomaJia Ruan, Peter Martin, Paul Christos, et al.
Blood|December 10, 2014
Flow sorting and exome sequencing reveal the oncogenome of primary Hodgkin and Reed-Sternberg cellsJonathan Reichel, Amy Chadburn, Paul G Rubinstein, et al.
Leukemia Research|May 21, 2023
Acute leukemias with complex karyotype show a similarly poor outcome independent of mixed, myeloid or lymphoblastic immunophenotype: A study from the Bone Marrow Pathology GroupTimothy Kirtek, Weina Chen, Dorottya Laczko, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|May 27, 2017
Oligomonocytic chronic myelomonocytic leukemia (chronic myelomonocytic leukemia without absolute monocytosis) displays a similar clinicopathologic and mutational profile to classical chronic myelomonocytic leukemiaJulia T Geyer, Wayne Tam, Yen-Chun Liu, et al.
Nature Cell Biology|March 2, 2010
Genome-wide RNA-mediated interference screen identifies miR-19 targets in Notch-induced T-cell acute lymphoblastic leukaemiaKonstantinos J Mavrakis, Andrew L Wolfe, Elisa Oricchio, et al.
Pageof 14

Showing results (71-80 of 140) with videos related to

Sort By:
Pageof 14
American Journal of Clinical Pathology|September 25, 2025
Guide to the diagnosis of lymphoid neoplasms in blood and bone marrow: A Bone Marrow Pathology Group approachKathryn Foucar, Adam Bagg, Daniel A Arber, et al.
Clinical Lymphoma, Myeloma & Leukemia|August 1, 2024
Expression of CD6 in Aggressive NK/T-cell Neoplasms and Assessment as a Potential Therapeutic Target: A Bone Marrow Pathology Group StudyXiaoxian Zhao, Chad M McCall, Jared G Block, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 22, 2012
Pegylated liposomal doxorubicin, rituximab, cyclophosphamide, vincristine, and prednisone in AIDS-related lymphoma: AIDS Malignancy Consortium Study 047Alexandra M Levine, Ariela Noy, Jeannette Y Lee, et al.
Blood|October 8, 2021
Oncogenic role of the SOX9-DHCR24-cholesterol biosynthesis axis in IGH-BCL2+ diffuse large B-cell lymphomasYajie Shen, Jingqi Zhou, Kui Nie, et al.
Leukemia & Lymphoma|May 4, 2019
Digital droplet PCR and next-generation sequencing refine minimal residual disease monitoring in acute lymphoblastic leukemiaIrene Della Starza, Lucia Anna De Novi, Alessandra Santoro, et al.
Blood|September 6, 2018
Five-year follow-up of lenalidomide plus rituximab as initial treatment of mantle cell lymphomaJia Ruan, Peter Martin, Paul Christos, et al.
Blood|December 10, 2014
Flow sorting and exome sequencing reveal the oncogenome of primary Hodgkin and Reed-Sternberg cellsJonathan Reichel, Amy Chadburn, Paul G Rubinstein, et al.
Leukemia Research|May 21, 2023
Acute leukemias with complex karyotype show a similarly poor outcome independent of mixed, myeloid or lymphoblastic immunophenotype: A study from the Bone Marrow Pathology GroupTimothy Kirtek, Weina Chen, Dorottya Laczko, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|May 27, 2017
Oligomonocytic chronic myelomonocytic leukemia (chronic myelomonocytic leukemia without absolute monocytosis) displays a similar clinicopathologic and mutational profile to classical chronic myelomonocytic leukemiaJulia T Geyer, Wayne Tam, Yen-Chun Liu, et al.
Nature Cell Biology|March 2, 2010
Genome-wide RNA-mediated interference screen identifies miR-19 targets in Notch-induced T-cell acute lymphoblastic leukaemiaKonstantinos J Mavrakis, Andrew L Wolfe, Elisa Oricchio, et al.
Pageof 14